Schedule Update - effective 1 February 2010 (text extract)

This is the text extract for Schedule Update - effective 1 February 2010, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 February 2010 Cumulative for January and February 2010 Section H cumulative for December 2009, and January, February 2010

Contents

Summary of PHARMAC decisions effective 1 February 2010 ......................... 3 Aromatase inhibitors – reference pricing ....................................................... 5 Sumatriptan – 50 mg & 100 mg tablets reference pricing ............................. 6 Betaloc CR price and subsidy reduction ......................................................... 6 Change to ordering of pregnancy tests ......................................................... 7 Fluticasone nasal spray – new listing ............................................................. 7 Dasatinib – 100 mg tablet listing .................................................................. 7 New brand of blood glucose meter and test strips (with lancets) funded .......................................................................................................... 8 Iron with Vitamin C tablets – delisting .......................................................... 8 Eye drops – dispensing clarification............................................................... 9 Pizotifen now fully subsidised ....................................................................... 9 Tender News ................................................................................................ 10 Looking Forward ......................................................................................... 10 Sole Subsidised Supply products cumulative to February 2010 ................... 11 New Listings ................................................................................................ 19 Changes to Restrictions ............................................................................... 21 Changes to Subsidy and Manufacturer’s Price............................................. 23 Changes to Sole Subsidised Supply ............................................................. 27 Changes to Section E Part I ......................................................................... 27 Delisted Items ............................................................................................. 28 Items to be Delisted .................................................................................... 30 Section H changes to Part II ........................................................................ 33 Index ........................................................................................................... 41

Summary of PharmaC decisions

effeCtive 1 feBrUarY 2010 New listings (pages 19-20) • Blood glucose diagnostic test meter (On Call Advanced) meter – subsidy by endorsement • Blood glucose diagnostic test strip (On Call Advanced) blood glucose test strips x 50 and lancets x 5, 1 OP – subsidy by endorsement • Sumatriptan (Arrow-Sumatriptan) tab 50 mg and 100 mg, 100 tab packs • Risperidone (Apo-Risperidone) tab 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, and oral liq 1 mg per ml • Risperidone (Dr Reddy’s Risperidone) tab 1 mg, 2 mg, 3 mg and 4 mg • Methylphenidate hydrochloride extended-release (Ritalin LA) cap modifiedrelease 10 mg – Special Authority – Retail pharmacy – only on a controlled drug form • Dasatinib (Sprycel) tab 100 mg – Special Authority • Letrozole (Letara) tab 2.5 mg • Promethazine hydrochloride (Promethazine Winthrop Elixir) oral liq 5 mg per 5 ml • Fluticasone propionate (Flixonase Hayfever & Allergy) metered aqueous nasal spray, 50 μg per dose, 120 dose OP Changes to restrictions (pages 21-22) • Pregnancy tests – HCG urine (MDS Quick Card) cassette – Only on a PSO, up to 200 test available on a PSO – addition of OP • Influenza vaccine (Fluvax, Fluarix, Vaxigrip) inj – amended access criteria • Exemestane (Aromasin) tab 25 mg – additional subsidy by Special Authority – Retail pharmacy – repeat dispensings for Aromasin tab 25 mg will be fully subsidised where the initial dispensing was before 1 February 2010 Decreased subsidy (pages 23-24) • Calcitriol (Calcitriol-AFT) cap 0.25 μg and 0.5 μg • Hydroxocobalamin (ABM Hydroxocobalamin) inj 1 mg per ml, 1 ml • Metoprolol succinate (Betaloc CR) tab long-acting 23.75 mg, 47.5 mg, 95 mg and 190 mg • Permethrin (Lyderm) crm 5% • Calcipotriol (Daivonex) crm 50 μg per g, 30 g OP and 100 g OP; oint 50 μg per g, 30 g OP and 100 g OP; and soln 50 μg per ml, 30 ml OP and 60 ml OP • Goserelin acetate (Zoladex) inj 3.6 mg and 10.8 mg • Sumatriptan (Arrow-Sumatriptan) tab 50 mg, 4 tab pack, and tab 100 mg, 2 tab pack • Sumatriptan (Imigran and Sumagran) tab 50 mg and 100 mg • Docetaxel (Baxter) inj 1 mg for ECP

Summary of PharmaC decisions – effective 1 february 2010 (continued) • Anastrozole (Arimidex) tab 1 mg • Exemestane (Aromasin) tab 25 mg increased subsidy (pages 23-24) • Flecainide acetate (Tambocor) tab 50 mg and 100 mg, and inj 10 mg per ml, 15 ml • Flecainide acetate (Tambocor CR) cap long-acting 100 mg and 200 mg • Sildenafil (Viagra) tab 25 mg and 100 mg

Pharmaceutical Schedule - Update News

Aromatase inhibitors – reference pricing

There are some changes to the subsidies of the aromatase inhibitors – anastrozole, letrozole and exemestane. These changes include the listing of a new brand of letrozole, as well as the reference pricing of anastrozole and exemestane to the subsidy for letrozole from 1 February 2010. The DP-Anastrozole brand of anastrozole and the Letara brand of letrozole will remain fully subsidised. In addition, AstraZeneca has recently notified that from 1 February 2010 the price for its brand of anastrozole (Arimidex) will be reduced to $26.55 per 30 tablet pack to match the reference priced subsidy. This means that Arimidex will also remain fully funded. Medsafe has approved DP-Anastrozole to be bioequivalent to Arimidex. From 1 February 2010, patients who are currently on exemestane, and any new patients, will need to have a Special Authority approval issued in order to receive full subsidy on this product. The new Special Authority form can be downloaded from the PHARMAC website at: www. pharmac.govt.nz/Schedule/SAForms. For patients already taking exemestane, where the initial dispensing for their current prescription occurred prior to 1 February 2010, any remaining dispensings on that prescription will be fully subsidised without the need for a Special Authority. However, the patient will require a valid Special Authority approval to receive fully subsidised exemestane with subsequent prescriptions. From 1 April 2010, subsidy on the Femara brand of letrozole will be reduced to match the subsidy of the Letara brand. Femara will be delisted from 1 July 2010. Medsafe has approved Letara to be bioequivalent to Femara.

6 Pharmaceutical Schedule - Update News

Sumatriptan – 50 mg & 100 mg tablets reference pricing

From 1 February 2010 there will be changes to the subsidies of sumatriptan 50 mg and 100 mg tablets. From 1 February, the 100-tablet packs of Arrow-Sumatriptan 50 mg and 100 mg tablets will be listed fully subsidised. Also from 1 February, the subsidy for the Imigran and Sumagran brands, and for the ArrowSumatriptan tab 50 mg 4-tablet pack and 100 mg 2-tablet pack, will be reduced to the level of the subsidy for the applicable strength of Arrow-Sumatriptan in 100-tablet packs via the application of reference pricing. From 1 May 2010, Arrow-Sumatriptan in

100-tablet packs will be the sole-subsidised brand of sumatriptan 50 mg and 100 mg tablets, with Imigran, Sumagran and the smaller pack sizes of Arrow-Sumatriptan no longer being subsidised. Patient information to help explain the changes are available to order from www. pharmaconline.co.nz.

Betaloc CR price and subsidy reduction

The price and subsidy for all strengths of Betaloc CR (metoprolol succinate) long-acting tablets will decrease from 1 February 2010. There is a further price and subsidy reduction for metoprolol succinate long-acting tablets that will occur on 1 July 2010.

Pharmaceutical Schedule - Update News

Change to ordering of pregnancy tests

Pregnancy tests – HCG urine cassettes will only be able to be ordered on a Practitioner’s Supply Order (PSO) from 1 February 2010. Up to 200 tests may be ordered at a time on a PSO and these will be dispensed from pharmacy as per other PSO listed items. This is a change from pregnancy tests – HCG urine cassettes only being available on a Wholesale Supply Order (WSO) and not being able to be dispensed from pharmacy. From 1 February 2010 orders will no longer be able to be processed on a WSO. Pharmacies will be able to claim Original Packs (OP) for pregnancy tests – HCG urine

cassettes from 1 February 2010, where order numbers are not multiples of 25 tests. MDS Quick Card, the subsidised brand of pregnancy tests – HCG urine cassettes, are distributed by MDS Diagnostics, PO Box 24-162, Royal Oak, Auckland. Phone 09 570 5761.

Fluticasone nasal spray – new listing

From 1 February 2010 fluticasone propionate metered aqueous nasal spray, 50 µg per dose (Flixonase Hayfever & Allergy) will be fully subsidised. This provides an alternative fully funded steroid nasal spray.

Dasatinib – 100 mg tablet listing

From 1 February 2010 a new 100 mg tablet strength of dasatinib (Sprycel) will be listed fully subsidised at a price and subsidy of $6,214.20 per 30 tablets. Dasatinib is subsidised subject to Special Authority restrictions for patients with Chronic Myeloid Leukaemia (CML). The listing of the 100 mg tablet strength is in addition to the currently listed 20 mg, 50 mg and 70 mg tablet strengths.

8 Pharmaceutical Schedule - Update News

New brand of blood glucose meter and test strips (with lancets) funded

PHARMAC is pleased to announce the listing of an additional brand of blood glucose diagnostic test strips with lancets and a blood glucose diagnostic test meter from 1 February 2010. The On Call Advanced meter will be fully subsidised and supplied by Airflow Products. This decision was notified in September last year and was originally to be supplied by Diabetes Supplies Limited. The Christchurch Diabetes Centre has undertaken a meter evaluation of the On Call Advanced brand of blood glucose diagnostic test strips and blood glucose diagnostic test meters. The independent study evaluated the accuracy and precision of the meter and showed, like the other funded meters, good performance under controlled conditions. We understand that the supplier of On Call Advanced intends to provide patients with the choice of a free meter swap out. PHARMAC intends to provide a resource shortly comparing all the specifications of the six fully subsidised blood glucose diagnostic test meters. In addition, results from the Christchurch Diabetes Centre evaluations are to be made available on our website in the near future.

Iron with Vitamin C tablets – delisting

Healtheries has advised that its Healtheries Iron with Vitamin C tablets (ferrous gluconate with ascorbic acid) has been discontinued as supply has been exhausted. As a result this product will be delisted from the Pharmaceutical Schedule in six months time. Individual iron and vitamin C products are already fully subsided on the Pharmaceutical Schedule and provide an alternative for patients requiring both of these products.

Pharmaceutical Schedule - Update News

Eye drops – dispensing clarification

PHARMAC has received correspondence from clinicians regarding pharmacy and eye drops. Some clinicians are prescribing 3 OP certified exemption and having this returned to them to be endorsed as 6 OP by the pharmacy without prior discussion. PHARMAC does not consider this appropriate as the clinician has decided the amount of product their patient requires. PHARMAC reminds pharmacists that if the prescription is amended and not subsequently endorsed by the prescriber, supply of a greater amount than ordered will not be subsidised. The Pharmacy Procedures Manual uses a convention of 12 drops per 1 ml in order to calculate the quantity of eye drops required. Note this is intended as a guideline only and some eye drops do provide greater than 12 drops per ml. Please clarify with the prescriber before supplying more product than initially prescribed if an amount is specified.

Pizotifen now fully subsidised

Novartis New Zealand Limited, under a Tender Agreement, has decreased the price of pizotifen (Sandomigran) 500 µg tablets to match the subsidy, resulting in pizotifen being fully subsidised from 1 February 2010. Sandomigran 500 µg tablets will have Sole Subsidised Supply status from 1 May 2010.

tender News

Sole Subsidised Supply changes – effective 1 March 2010

Chemical Name Cephalexin monohydrate Cephalexin monohydrate Diclofenac sodium Diclofenac sodium Pegylated interferon alpha-2A Pegylated interferon alpha-2A Pegylated interferon alpha-2A Pegylated interferon alpha-2A Pegylated interferon alpha-2A Pegylated interferon alpha-2A Presentation; Pack size Grans for oral liq 125 mg per 5 ml; 100 ml Grans for oral liq 250 mg per 5 ml; 100 ml Tab EC 25 mg; 50 tab Tab EC 50 mg; 50 tab Inj 135 µg prefilled syringe; 1 inj and 4 inj Inj 180 µg prefilled syringe; 1 inj and 4 inj Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112; 1 OP Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168; 1 OP Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112; 1 OP Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168; 1 OP Sole Subsidised Supply brand (and supplier) Cefalexin Sandoz (Sandoz) Cefalexin Sandoz (Sandoz) Diclohexal (Sandoz) Diclohexal (Sandoz) Pegasys (Roche) Pegasys (Roche) Pegasys RBV Combination Pack (Roche) Pegasys RBV Combination Pack (Roche) Pegasys RBV Combination Pack (Roche) Pegasys RBV Combination Pack (Roche)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for implementation 1 march 2010 • Bimatoprost (Lumigan) eye drops 0.03% - subsidy decrease • Danazol (Azol) cap 200 mg – new listing • Multivitamin (A, D, E, K) (Vitabdeck) cap – new listing under Special Authority criteria • Sulphasalazine tab 500 mg (Salazopyrin) and tab EC 500 mg – price and subsidy increase • Travoprost (Travatan) eye drops 0.004% - subsidy decrease • Ursodeoxycholic acid (Actigall) cap 300 mg – amend Special Authority criteria

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Acarbose Acetazolamide Allopurinol Alprazolam Amantadine hydrochloride Amlodipine Amoxycillin

Presentation

Tab 50 mg & 100 mg Tab 250 mg Tab 100 mg & 300 mg Tab 250 µg, 500 µg & 1 mg Cap 100 mg Tab 5 mg & 10 mg Drops 125 mg per 1.25 ml Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg

Brand Name Expiry Date*

Glucobay Diamox Apo-Allopurinol Arrow-Alprazolam Symmetrel Apo-Amlodipine Ospamox Paediatric Drops Ibiamox Apo-Amoxi Synermox AFT Ethics Aspirin Ethics Aspirin EC Pacific Atenolol AstraZeneca Arrow-Azithromycin Pacifen Sandoz Beta Scalp Fibalip Bicalox Lax-Tabs AFT Marcain Isobaric Marcain Heavy healthE API Miacalcic Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Zinacef 2012 2011 2011 2010 2011 2011 2011 2010 2011 2011 2010 2012 2012 2012 2012 2011 2012 2011 2011 2010 2011 2010 2012 2011 2011 2011 2010 2010 2011 2011

Amoxycillin clavulanate Aqueous cream Aspirin Atenolol Atropine sulphate Azithromycin Baclofen Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcium Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium

Tab amoxycillin 500 mg with potassium clavulanate 125 mg Crm 500 g Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 500 mg Tab 10 mg Inj 1 mega u Scalp app 0.1% Tab 200 mg Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Tab eff 1 g Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg & 1.5 g

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Ciprofloxacin Citalopram Clarithromycin Clobetasol propionate

Presentation

Crm BP Tab 10 mg Oral liq 1 mg per ml Eye oint 1% Soln 4% Nail soln 8% Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Oint 0.05% Scalp app 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg Crm 1% Vaginal crm 1% with applicator(s) Vaginal crm 2% with applicators(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg & 100 mg Inj 500 mg Nasal spray 10 µg per dose Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

PSM Zetop Cetirizine-AFT Chlorsig Orion Batrafen Rex Medical Arrow-Citalopram Klamycin Klacid Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Mayne Desmopressin-PH&T PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit 2010 2011 2012 2011 2012 2011 2011 2010 2012

Clonazepam Clonidine

2011 2012

Clonidine hydrochloride

2012

Clotrimazole

2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Desferrioxamine mesylate Desmopressin Dexamphetamine sulphate Dextrose Dextrose with electrolytes

2010 2010 2010 2010 2010 2012 2010 2012 2010 2011 2010 2011 2010

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Diclofenac sodium

Presentation

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab 30 mg & 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Tab 400 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab long-acting 5 mg Tab long-acting 10 mg Oral liq 150 mg per 5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored

Brand Name Expiry Date*

Voltaren Ophtha Voltaren Voltaren Dilzem Cardizem CD Pytazen SR Apo-Doxazosin AFT Clexane Comtan E-Mycin E-Mycin E-Mycin NZ Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Felo 5 ER Felo 10 ER Ferodan Fintral AFT AFT Flucloxin Pacific Fludara Fludara Oral Ultraproct Ultraproct 2012 2010 2011 2012 2011 2011 2011 2010 2011

Diltiazem hydrochloride

2011

Dipyridamole Doxazosin mesylate Emulsifying ointment Enoxaparin sodium (low molecular weight heparin) Entacapone Erythromycin ethyl succinate

2011 2010 2011 2012 2012 2012 2011 2012 2010

Ethinyloestradiol Ethinyloestradiol with norethisterone

Felodipine Ferrous sulphate Finasteride Flucloxacillin sodium

Fluconazole Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

Fluoromethalone Fluoxetine hydrochloride

FML Fluox Fluox

2012 2010

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Fluticasone propionate Furosemide Fusidic acid Gabapentin Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Presentation

Metered aqueous nasal spray, 50 µg per dose Tab 40 mg Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg & 10 mg

Brand Name Expiry Date*

Flixonase Hayfever & Allergy Diurin 40 Foban Foban Nupentin Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual Pumpspray Nitroderm TTS Serenace Serenace Douglas ABM PSM Colifoam Locoid DP Lotn HC Plaquenil Methopt Buscopan Gastrosoothe Ethics Ibuprofen Fenpaed Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Oratane Sporanox Sebizole Duphalac Betagan Xylocaine Xylocaine Xylocaine 31/1/13 2012 2010 31/7/12 2012 2011 2011 2011

Haloperidol Hydrocortisone

Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Powder Crm 1% Rectal foam 10%, CFC-free (14 applications) Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Tab 200 mg Eye drops 0.5% Inj 20 mg, 1 ml Tab 20 mg Tab 200 mg Oral liq 100 mg per 5 ml Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml

2010 2012 2011 2012 2010 2011 2012 2011 2011 2012 2010 2010

Hydrocortisone acetate Hydrocortisone butyrate Hydrocortisone with wool fat and mineral oil Hydroxychloroquine sulphate Hypromellose Hysocine N-butylbromide Ibuprofen Ipratropium bromide

Iron polymaltose Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Lignocaine hydrochloride

2011 2012 2010 2011 2010 2010 2010

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Lignocaine with prilocaine

Presentation

Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Derbac M A-Lices Foremount Child’s Silicone Mask De-Worm Colofac Provera Pentasa Biodone Biodone Forte Biodone Extra Forte Methatabs Methoblastin Methotrexate Ebewe Methotrexate Ebewe Prodopa Medrol Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Multichem RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Mayne Mayne 2012 2010 2010 2010

Lisinopril Loperamide hydrochloride Loratadine

Malathion Mask for Spacer Device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Methadone hydrochloride

Liq 0.5% Shampoo 1% Device Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Tab 2.5 mg & 10 mg Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 125 mg, 250 mg & 500 mg Tab 4 mg & 100 mg Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Crm 2% Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab immediate release 10 mg & 20 mg Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml

2010 2011 30/9/11 2011 2011 2010 2012 2012 2010 2012 2011 2011 2012 2011 2011 2012

Methotrexate

Methyldopa Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

Metoclopramide hydrochloride Miconazole nitrate Morphine hydrochloride

2011 2011 2012

Morphine sulphate

2012 2011

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine

Presentation

Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Brand Name Expiry Date*

Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Habitrol Noriday 28 Primolut N Norpress Nilstat Nilstat Nilstat Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Pantocid IV Dr Reddy’s Pantoprazole Pharmacare Paracare Junior Paracare Double Strength 2010 2010 2012 2010 2010 2012

Nicotine

Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit) Gum 2 mg & 4 mg (Mint) Tab 350 µg Tab 5 mg Tab 10 mg & 25 mg Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Cap 10 mg, 20 mg & 40 mg Inj 40 mg

2010

Norethisterone Nortriptyline hydrochloride Nystatin

2012 2011 2011 2011 2010 2011

Omeprazole

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml & 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml

2010 2010 2010 2012

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

2011

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak Flow Meter Pergolide Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pioglitazone Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone Prednisone sodium phosphate Procaine penicillin Promethazine Quinapril Quinapril with hydroclorothiazide

Presentation

Eye oint with soft white paraffin Tab 20 mg Low range and Normal range Tab 0.25 mg & 1 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg & 500 mg Eye drops 0.12% Tab 15 mg, 30 mg & 45 mg Oral drops 10% Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg, 2.5 mg, 5 mg & 20 mg Oral liq 5 mg per ml Inj 1.5 mega u Tab 10 mg & 25 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg and 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg

Brand Name Expiry Date*

Lacri-Lube Loxamine Breath-Alert Permax AFT AFT Cilicaine VK Prefrin Pizaccord Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Redipred Cilicaine Allersoothe Accupril Accuretic 10 Accuretic 20 Q 300 Peptisoothe Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Salapin Duolin 2012 2010 2010 2010 2012 2012 2010 2012 2010 2010 30/9/11 2011 2010

2010 2012 2011 2011 2012 2010 2011 2012 2011 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Simvastatin

Apo-Selegiline Arrow-Simva 10 mg Arrow-Simva 20 mg Arrow-Simva 40 mg Arrow-Simva 80 mg

2012 2011

Sole Subsidised Supply Products – cumulative to February 2010

Generic Name

Sodium citro-tartrate Sodium cromoglycate Sotalol Spacer Device Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terazosin hydrochloride Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate Triamcinolone acetonide

Presentation

Grans eff 4 g sachets Nasal spray, 4% Tab 80 mg & 160 mg 230 ml Liq Soln 2.3% Tab 10 mg Tab 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 µg Inj 1 mg per ml, 1 ml Tab 10 mg Eye drops 0.25% & 0.5% Crm 0.02% Oint 0.02% Inj 40 mg per ml, 1 ml 0.1% in Dental Paste USP Tab 300 mg Cap 300 mg Inj 50 mg per ml, 10 ml Oint BP Cap 220 mg Tab 7.5 mg

Brand Name Expiry Date*

Ural Rex Mylan Space Chamber Midwest Pinetarsol Normison Apo-Terazosin Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timol Apo-Timop Aristocort Aristocort Kenacort-A40 Oracort TMP Actigall Pacific PSM Zincaps Apo-Zopiclone 2010 2012 2012 30/9/11 2010 2011 2011 2010 2011 2011 2011 2012 2011 2011

Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Zinc and castor oil Zinc sulphate Zopiclone February changes in bold

2011 2011 2011 2011 2011 2011

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 February 2010

31 BLOOD GLUCOSE DIAGNOSTIC TEST METER – Subsidy by endorsement a) Maximum of 1 meter per prescription b) 1) A diagnostic blood glucose test meter is subsidised for patients who begin insulin or sulphonylurea therapy after 1 March 2005 or is prescribed for a pregnant woman with diabetes. 2) Only one meter per patient. No further prescriptions will be subsidised. The prescription must be endorsed accordingly. Meter ........................................................................................ 9.00 1 ✔ On Call Advanced BLOOD GLUCOSE DIAGNOSTIC TEST STRIP The number of test strips available on a prescription is restricted to 50 unless: 1) Prescribed with insulin or a sulphonylurea but are on a different prescription and the prescription is endorsed accordingly; or 2) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3) Prescribed for a pregnant woman with diabetes and endorsed accordingly. Blood glucose test strips × 50 and lancets × 5 ...................... 19.10 1 OP ✔ On Call Advanced SUMATRIPTAN Tab 50 mg ............................................................................. 38.83 Tab 100 mg ........................................................................... 77.66 RISPERIDONE Tab 0.5 mg .............................................................................. 3.51 Tab 1 mg ................................................................................. 6.00 Tab 2 mg ............................................................................... 11.00 Tab 3 mg ............................................................................... 15.00 Tab 4 mg ............................................................................... 20.00 Oral liq 1 mg per ml ................................................................ 18.35 134 100 100 60 60 60 60 60 30 ml ✔ Arrow-Sumatriptan ✔ Arrow-Sumatriptan ✔ Apo-Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone

119

125

METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE – Special Authority see SA0924 – Retail pharmacy Only on a controlled drug form Cap modified-release 10 mg ................................................... 19.50 30 ✔ Ritalin LA DASATINIB – Special Authority see SA0976 Tab 100 mg ...................................................................... 6,214.20 LETROZOLE Tab 2.5 mg ............................................................................ 26.55 PROMETHAZINE HYDROCHLORIDE ❋‡ Oral liq 5 mg per 5 ml ............................................................. 3.10 30 30 100 ml ✔ Sprycel ✔ Letara ✔ Promethazine Winthrop Elixir

144 146 151

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 February 2010 (continued)

155 FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose ......................... 13.34 120 dose OP ✔ Flixonase Hayfever & Allergy

Effective 1 January 2010

26 52 MESALAZINE Tab EC 500 mg ...................................................................... 49.50 PINDOLOL ❋ Tab 5 mg ................................................................................. 5.40 ❋ Tab 10 mg ............................................................................... 9.19 ❋ Tab 15 mg ............................................................................. 13.80 SILVER SULPHADIAZINE Crm 1% .................................................................................. 12.30 a) Up to 250 g available on a PSO b) Not in combination 100 100 100 100 50 g OP ✔ Asamax ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Flamazine

SOLIFENACIN SUCCINATE – Special Authority see SA0998 – Retail pharmacy Tab 5 mg ................................................................................ 56.50 30 ✔ Vesicare Tab 10 mg .............................................................................. 56.50 30 ✔ Vesicare ➽ SA0998 Special Authority for Subsidy Initial application from any relevant practitioner. Applications valid without further renewal unless notified for applications where the patient has overactive bladder and a documented intolerance of oxybutynin. FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 cap available on a PSO ....................... 32.00 Cap 500 mg ......................................................................... 110.00 PARACETAMOL WITH CODEINE ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ............. 2.45 250 500 100 ✔ AFT ✔ AFT ✔ ParaCode

112

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 February 2010

73 PREGNANCY TESTS - HCG URINE – Only on a PSO WSO Cassette – Up to 200 test available on a PSO ......................... 19.00 25 test OP ✔ MDS Quick Card Distributed by MDS Diagnostics, PO Box 24-162, Royal Oak, Auckland. Ph 09 570 5761 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] A) is available between 1 March and 30 June each year for patients who meet the following criteria, as set by the Ministry of Health: a) all people 65 years of age and over; b) people under 65 years of age with: i) the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii) diabetes; iv) chronic renal disease; v) any cancer, excluding basal and squamous skin cancers if not invasive; vi) the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, or g) children on long term aspirin. c) people under 65 years of age who are: (i) pregnant; or (ii) morbidly obese d) children under the age of 5 who are enrolled with an Access Primary Health Organisation The following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease, c) pregnancy in the absence of another risk factor. B) Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. C) Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. D) Influenza Vaccine does not fall within the definition Community Pharmaceutical as it is not funded directly from the Pharmaceutical Budget. Pharmacists are unable to claim for the dispensing of influenza vaccine from the Funder. Inj ............................................................................................ 9.00 1 ✔ Fluvax ✔ Fluarix 90.00 10 ✔ Fluarix ✔ Vaxigrip

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 February 2010 (continued)

146 EXEMESTANE – Additional subsidy by Special Authority see SA1000 – Retail pharmacy Tab 25 mg ............................................................................. 26.55 30 (175.00) Aromasin ➽ SA1000 Special Authority for Alternate Subsidy Initial Application – from any relevant practitioner. Approvals valid for 5 years for applications meeting the following criteria: All of the following: 1. Patient is a postmenopausal woman; and 2. Patient has hormone receptor positive breast cancer; and 3. Any of the following 3.1 The patient was receiving funded exemestane prior to 1 February 2010; or 3.2 The patient has advanced breast cancer and a very clear history of intolerance to anastrozole or letrozole; or 3.3 The patient has advanced breast cancer and disease has progressed following treatment with anastrozole or letrozole. Renewal from any relevant practitioner. Approvals valid without further renewal unless notified where the treatment remains appropriate and the patient is benefitting from treatment. Note – Repeat dispensings for Aromasin tab 25 mg will be fully subsidised where the initial dispensing was before 1 February 2010.

Effective 1 January 2010

79 SOMATROPIN GROWTH HORMONE BIOSYNTHETIC HUMAN – Special Authority see SA0755 ❋ Inj cartridge 16 iu per vial ..................................................... 249.60 1 ✔ Genotropin 1,248.00 5 ✔ Genotropin ❋ Inj cartridge 36 iu per vial ..................................................... 561.60 1 ✔ Genotropin 2,808.00 5 ✔ Genotropin SOMATROPIN RECOMBINANT HUMAN GROWTH HORMONE – Special Authority see SA0755 ❋ Inj 5 mg ............................................................................... 300.00 1 ✔ Norditropin SimpleXx 5 mg ❋ Inj 10 mg ............................................................................. 600.00 1 ✔ Norditropin SimpleXx 10 mg ❋ Inj 15 mg ............................................................................. 900.00 1 ✔ Norditropin SimpleXx 15 mg CYCLOSPORIN A – Hospital pharmacy [HP3] Cap 25 mg ............................................................................. 59.50 50 Cap 50 mg ........................................................................... 118.54 50 Cap 100 mg ......................................................................... 237.08 50 Oral liq 100 mg per ml .......................................................... 264.17 50 ml OP Note – change in chemical name from cyclosporin A to cyclosporin only. ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

149

179

ORAL FEED 1.5KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid (coffee latte) .................................................................. 1.33 237 ml OP ✔ Ensure Plus

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 February 2010

36 CALCITRIOL ( subsidy) ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 36 HYDROXOCOBALAMIN ( subsidy) ❋ Inj 1 mg per ml, 1 ml – Up to 6 inj available on a PSO ................ 6.15 FLECAINIDE ACETATE – Retail pharmacy–Specialist ( subsidy) ▲ Tab 50 mg .............................................................................. 45.82 ▲ Tab 100 mg ............................................................................ 80.92 ▲ Cap long-acting 100 mg .......................................................... 45.82 ▲ Cap long-acting 200 mg .......................................................... 80.92 Inj 10 mg per ml, 15 ml ........................................................... 52.45 METOPROLOL SUCCINATE ( subsidy) ❋ Tab long-acting 23.75 mg ......................................................... 2.73 ❋ Tab long-acting 47.5 mg ........................................................... 3.41 ❋ Tab long-acting 95 mg .............................................................. 5.88 ❋ Tab long-acting 190 mg .......................................................... 10.63 100 100 3 ✔ Calcitriol-AFT ✔ Calcitriol-AFT ✔ ABM Hydroxocobalamin ✔ Tambocor ✔ Tambocor ✔ Tambocor CR ✔ Tambocor CR ✔ Tambocor ✔ Betaloc CR ✔ Betaloc CR ✔ Betaloc CR ✔ Betaloc CR ✔ Viagra ✔ Viagra

60 60 30 30 5 30 30 30 30

SILDENAFIL – Special Authority see SA0968 – Hospital pharmacy [HP1] ( subsidy) Tab 25 mg .............................................................................. 52.00 4 Tab 100 mg ............................................................................ 68.00 4 PERMETHRIN ( subsidy) Crm 5% .................................................................................... 3.65 (4.20) CALCIPOTRIOL ( subsidy) Crm 50 µg per g...................................................................... 20.20 56.32 Oint 50 µg per g ...................................................................... 20.20 56.32 Soln 50 µg per ml ................................................................... 20.22 33.79 GOSERELIN ACETATE – Hospital pharmacy [HP3] ( subsidy) Inj 3.6 mg ............................................................................. 200.00 Inj 10.8 mg ........................................................................... 500.00 SUMATRIPTAN ( subsidy) Tab 50 mg ................................................................................ 1.55 (12.00) (22.00) Tab 100 mg .............................................................................. 1.55 (12.00) (22.00) 30 g OP

Lyderm 30 g OP 100 g OP 30 g OP 100 g OP 30 ml OP 60 ml OP 1 1 4 2 ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Zoladex ✔ Zoladex ✔ Arrow-Sumatriptan Sumagran Imigran ✔ Arrow-Sumatriptan Sumagran Imigran

119

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 February 2010 (continued)

120 140 145 146 PIZOTIFEN ( price) ❋ Tab 500 µg ............................................................................ 21.10 100 ✔ Sandomigran ✔ Baxter ✔ Arimidex

DOCETAXEL – PCT only – Specialist – Special Authority see SA0880 ( subsidy) Inj 1 mg for ECP ..................................................................... 17.55 1 mg ANASTROZOLE ( subsidy) Tab 1 mg ............................................................................... 26.55 30

EXEMESTANE – Additional subsidy by Special Authority see SA1000 – Retail pharmacy ( subsidy) Tab 25 mg .............................................................................. 26.55 30 (175.00) Aromasin

Effective 1 January 2010

30 METFORMIN HYDROCHLORIDE ( subsidy) ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 GLYCEROL ( subsidy) ❋ Suppos 3.6 g – Only on a prescription ....................................... 6.00 CHOLECALCIFEROL ( subsidy) ❋ Tab 1.25 mg (50,000 iu) – Maximum of 12 tab per prescription........................................ 7.76 FOLIC ACID ( subsidy) ❋ Tab 0.8 mg ............................................................................ 19.80 ❋ Tab 5 mg ............................................................................... 10.21 HYDROCORTISONE BUTYRATE ( subsidy) Lipocream 0.1% ........................................................................ 2.30 6.85 Oint 0.1% .................................................................................. 6.85 Milky emul 0.1% ........................................................................ 6.85 500 250 20 ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ PSM

34 37

12 1,000 500 30 g OP 100 g OP 100 g OP 100 ml OP

✔ Cal-d-Forte ✔ Apo-Folic Acid ✔ Apo-Folic Acid ✔ Locoid Lipocream ✔ Locoid Lipocream ✔ Locoid ✔ Locoid Crelo

HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN – Only on a prescription ( subsidy) Crm 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort MOMETASONE FUROATE ( subsidy) Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 WOOL FAT WITH MINERAL OIL – Only on a prescription ( price) ❋ Lotn hydrous 3% with mineral oil ............................................... 1.40 (3.50) HYDROCORTISONE BUTYRATE ( subsidy) Scalp lotn 0.1% ......................................................................... 3.65 15 g OP 45 g OP 15 g OP 45 g OP 250 ml OP Hydroderm Lotion 100 ml OP ✔ Locoid ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

72 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Inj 150 mg per ml, 1 ml syringe – Up to 5 inj available on a PSO ............................................. 7.15 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ( subsidy) ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) MEDROXYPROGESTERONE ACETATE ❋ Tab 2.5 mg ( subsidy) ............................................................. 3.09 ❋ Tab 5 mg ( subsidy) .............................................................. 13.06 ❋ Tab 10 mg ( subsidy) .............................................................. 6.85 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Tab 100 mg – Retail pharmacy – Specialist ............................. 96.50 ❋ Tab 200 mg – Retail pharmacy – Specialist ............................. 70.50 SOMATROPIN – Special Authority see SA0755 ( subsidy) ❋ Inj cartridge 16 iu per vial ...................................................... 249.60 1,248.00 ❋ Inj cartridge 36 iu per vial ...................................................... 561.60 2,808.00 CABERGOLINE ( subsidy) Tab 0.5 mg – Maximum of 2 tab per prescription; can be waived by Special Authority see SA0175 .................. 16.50 66.00 AMOXYCILLIN CLAVULANATE ( subsidy) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) CLINDAMYCIN ( subsidy) Inj phosphate 150 mg per ml, 4 ml – Retail pharmacy – Specialist............................................................................. 16.00 ISONIAZID – Retail pharmacy – Specialist ( subsidy) No patient co-payment payable ❋ Tab 100 mg ............................................................................ 20.00 ETIDRONATE DISODIUM ( subsidy) ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95

1 84

✔ Depo-Provera

Estelle 35-ED 30 100 30 100 30 1 5 1 5 ✔ Provera ✔ Provera ✔ Provera ✔ Provera ✔ Provera ✔ Genotropin ✔ Genotropin ✔ Genotropin ✔ Genotropin

2 8

✔ Dostinex ✔ Dostinex

100 ml Augmentin 100 ml Augmentin

✔ Dalacin C

100 60 100

✔ PSM

108

Didronel ✔ Etidrate

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

109 QUININE SULPHATE ( price) ❋ Tab 200 mg ............................................................................ 15.95 (17.20) ‡ Safety cap for extemporaneously compounded oral liquid preparations. CODEINE PHOSPHATE ( subsidy) Tab 15 mg ................................................................................ 5.39 Tab 30 mg ................................................................................ 8.25 Tab 60 mg .............................................................................. 17.76 PETHIDINE HYDROCHLORIDE ( subsidy) a) Only on a controlled drug form b) No patient co-payment payable Tab 50 mg ................................................................................ 3.20 Tab 100 mg .............................................................................. 4.20 PHENOBARBITONE ( subsidy) ❋ Tab 15 mg .............................................................................. 25.00 ❋ Tab 30 mg .............................................................................. 26.00 ALPRAZOLAM – Month Restriction ( subsidy) Tab 250 µg .............................................................................. 3.15 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 µg .............................................................................. 4.10 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg .................................................................................. 7.25 ‡ Safety cap for extemporaneously compounded oral liquid preparations. 250 Q 200

111

100 100 100

✔ PSM ✔ PSM ✔ PSM

113

10 10 500 500 50 50 50

✔ PSM ✔ PSM ✔ PSM ✔ PSM ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam

118

127

131

DEXAMPHETAMINE SULPHATE – Special Authority see SA0907 – Retail pharmacy ( subsidy) Only on a controlled drug form Tab 5 mg ................................................................................ 16.50 100 ✔ PSM OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 ( subsidy) Inj 1 mg for ECP ........................................................................ 1.42 1 mg CYCLOSPORIN – Hospital pharmacy [HP3] ( subsidy) Cap 25 mg .............................................................................. 59.50 Cap 50 mg ............................................................................ 118.54 Cap 100 mg .......................................................................... 237.08 Oral liq 100 mg per ml ........................................................... 264.17 50 50 50 50 ml OP ✔ Baxter ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

136 149

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Sole Subsidised Supply

Effective 1 February 2010

For the list of new Sole Subsidised Supply products effective 1 February 2010 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 11-18.

Changes to Section E Part I

Effective 1 February 2010

Pharmaceuticals and quantities that may be obtained on a Practitioner’s Supply Order 189 PREGNANCY TESTS – HCG URINE ✔ Cassette 200 test Pharmaceuticals that may be obtained on a Wholesale Supply Order 190 PREGNANCY TESTS - HCG URINE ✔ Cassette

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 February 2010

30 GLIBENCLAMIDE ❋ Tab 2.5 mg .............................................................................. 3.78 ❋ Tab 5 mg ................................................................................. 3.31 ACEBUTOLOL ❋ Cap 100 mg ............................................................................. 9.50 TRIAMTERENE WITH HYDROCHLOROTHIAZIDE ❋ Tab 50 mg with hydrochlorothiazide 25 mg ............................... 5.00 ISOTRETINOIN – Special Authority see SA0955 – Retail pharmacy Cap 10 mg ............................................................................. 26.93 Cap 20 mg ............................................................................. 38.72 SAQUINAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Tab 500 mg ......................................................................... 556.59 DIAZEPAM Tab 2 mg – Month Restriction.................................................... 8.40 ‡ Safety cap for extemporaneously compounded oral liquid preparations. AZATADINE MALEATE ❋ Tab 1 mg ................................................................................. 6.94 (16.90) BECLOMETHASONE DIPROPIONATE Aerosol inhaler, 50 µg per dose ................................................ 8.54 Aerosol inhaler, 100 µg per dose ............................................ 12.50 Aerosol inhaler, 250 µg per dose ............................................ 22.67 Note – Beclazone CFC-free aerosol inhalers were listed 1 July 2009 PILOCARPINE ❋ Eye drops 6% ........................................................................... 8.56 100 100 100 100 100 100 120 500 ✔ Gliben ✔ Gliben ✔ ACB ✔ Triamizide ✔ Isotane 10 ✔ Isotane 20 ✔ Invirase ✔ Pro-Pam

51 54 58

93 127

150

50 Zadine 200 dose OP ✔ Beclazone 50 200 dose OP ✔ Beclazone 100 200 dose OP ✔ Beclazone 250

151

160

15 ml OP

✔ Pilopt

Effective 1 January 2010

60 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 2.78 (3.02) Lotn, BP .................................................................................. 16.70 (19.44) MEDROXYPROGESTERONE ACETATE ❋ Inj 150 mg per ml, 1 ml – Up to 5 inj available on a PSO ............ 8.05 CO-TRIMOXAZOLE ❋ Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml – Up to 200 ml available on a PSO............... 5.90

100 g ABM 2,000 ml ABM 1 ✔ Depo-Provera

72 86

500 ml

✔ Trisul

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 January 2010 (continued)

151 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab long-acting 6 mg ................................................................ 2.70 (7.73) 5.40 (12.56) PILOCARPINE ❋ Eye drops 2% ............................................................................ 4.32 20 Polaramine Repetab 40 Polaramine Repetab 15 ml OP ✔ Pilopt

160

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 April 2010

30 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 MOMETASONE FUROATE Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) AMOXYCILLIN CLAVULANATE Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) ETIDRONATE DISODIUM ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95 500 250 15 g OP 45 g OP 15 g OP 45 g OP 84 Estelle 35-ED ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

100 ml Augmentin 100 ml Augmentin 60 100 Didronel ✔ Etidrate

108

Effective 1 May 2010

36 CALCITRIOL ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 64 PERMETHRIN Crm 5% .................................................................................... 3.65 (4.20) AMOXYCILLIN Grans for oral liq 250 mg per 5 ml – Up to 200 ml available on a PSO ................................................................. 1.27 100 100 30 g OP Lyderm ✔ Calcitriol-AFT ✔ Calcitriol-AFT

100 ml

✔ Ranbaxy Amoxicillin

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 May 2010 (continued)

119 SUMATRIPTAN Tab 50 mg ................................................................................ 1.55 (12.00) (22.00) Tab 100 mg .............................................................................. 1.55 (12.00) (22.00) 4 2 ✔ Arrow-Sumatriptan Sumagran Imigran ✔ Arrow-Sumatriptan Sumagran Imigran

Effective 1 July 2010

59 SILVER SULPHADIAZINE Crm 1% with chlorhexidine digluconate 0.2% ........................... 15.04 a) Up to 500 g available on a PSO b) Not in combination HYDROCORTISONE BUTYRATE Milky emul 0.1% ........................................................................ 5.00 DITHRANOL Crm 1% ................................................................................... 27.50 SOMATROPIN – Special Authority see SA0755 ❋ Inj 5 mg ................................................................................ 300.00 ❋ Inj 10 mg .............................................................................. 600.00 ❋ Inj 15 mg .............................................................................. 900.00 138 FLUDARABINE PHOSPHATE – PCT only – Specialist Tab 10 mg ........................................................................... 650.25 100 g OP ✔ Silvazine

62 65 80

30 ml OP 50 g OP 1 1 1

✔ Locoid Crelo ✔ Micanol ✔ Norditropin SimpleXx 5 mg ✔ Norditropin SimpleXx 10 mg ✔ Norditropin SimpleXx 15 mg ✔ Fludara

Effective 1 August 2010

34 38 95 BISACODYL – Only on a prescription ❋ Suppos 10 mg .......................................................................... 3.96 FERROUS GLUCONATE WITH ASCORBIC ACID ❋ Tab 170 mg with ascorbic acid 40 mg ..................................... 12.04 12 500 ✔ Fleet ✔ Healtheries Iron with Vitamin C

INTERFERON ALPHA-2A – PCT – Hospital pharmacy [HP3]-Specialist a) See prescribing guideline b) Only one multidose cartridge starter pack to be prescribed and dispensed per patient. Inj 4.5 m iu prefilled syringe .................................................... 46.98 1 ✔ Roferon-A Inj 18 m iu multidose cartridge .............................................. 187.92 1 ✔ Roferon-A Inj 18 m iu multidose cartridge × 2 starter pack ................... 375.84 1 ✔ Roferon-A

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 August 2010 (continued)

95 INTERFERON ALPHA-2A WITH RIBAVIRIN – Special Authority see SA0784 – Hospital pharmacy [HP3] See prescribing guideline Inj 18 m iu multidose cartridge × 2 with ribavirin tab 200 mg × 168 .............................. 1,375.84 1 OP ✔ Roferon RBV Combination Pack Inj 18 m iu multidose cartridge × 2 with pen and needles with ribavirin tab 200 mg × 168 ............................................ 1,375.84 1 OP ✔ Roferon RBV Combination Pack Starter Kit TRIMIPRAMINE MALEATE Cap 50 mg .............................................................................. 11.20 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab long-acting 6 mg ................................................................ 5.40 (12.56) 2.70 (7.73) 100 40 Polaramine ColourFree Repetab 20 Polaramine ColourFree Repetab ✔ Tripress

114 151

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 February 2010

BLOOD GLUCOSE DIAGNOSTIC TEST METER Meter .............................................On Call Advanced 9.00 1

BLOOD GLUCOSE DIAGNOSTIC TEST STRIP Blood glucose test strips x 50 and lancets x 5 .................................On Call Advanced 19.10 CALCIPOTRIOL ( price) Crm 50 µg per g .............................Daivonex Oint 50 µg per g .............................Daivonex Crm 50 µg per g .............................Daivonex Oint 50 µg per g .............................Daivonex Soln 50 µg per ml...........................Daivonex Soln 50 µg per ml...........................Daivonex 20.20 20.20 56.32 56.32 20.22 33.79

1 30 g 30 g 100 g 100 g 30 ml 60 ml 1 1 1 1% 1% Apr-10 Apr-10 (B) (B)

CEFEPIME HYDROCHLORIDE ( price and addition of HSS) Inj 1 g, 15 ml ..................................Maxipime 19.55 Inj 2 g, 77 ml ..................................Maxipime 39.10 DACLIZUMAB Inj 25 mg per 5 ml vial ....................Zenapax 635.00 Note – Zenapax inj 25 mg per 5 ml vial to be delisted 1 April 2010. DASATINIB Tab 100 mg....................................Sprycel FLECAINIDE ACETATE Tab 50 mg......................................Tambocor Tab 100 mg....................................Tambocor Cap long-acting 100 mg .................Tambocor CR Cap long-acting 200 mg .................Tambocor CR Inj 10 mg per ml, 15 ml ..................Tambocor GOSERELIN ACETATE ( price) Inj 3.6 mg.......................................Zoladex Inj 10.8 mg.....................................Zoladex HYDROXOCOBALAMIN ( price and addition of HSS) Inj 1 mg per ml, 1 ml ......................ABM 6,214.20 45.82 80.92 45.82 80.92 52.45 200.00 500.00 6.15

30 60 60 30 30 5 1 1 3 1% Apr-10 Neo-B12 Neo-Cytamen

Note – Neo-B12 inj 1 mg per ml, 1 ml to be delisted 1 April 2010. IRON SUCROSE Inj 20 mg per ml, 5 ml ....................Venofer LETROZOLE Tab 2.5 mg.....................................Letara Note – Femara tab 2.5 mg to be delisted 1 April 2010. Products with Hospital Supply Status (HSS) are in bold. (B) – Subject only to part (b) of the definition of “DV Pharmaceutical” 100.00 26.55 5 30 1% 1% Apr-10 Apr-10 (B) Femara Letrozole Sandoz

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 February 2010 (continued)

METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE Cap modified-release 10 mg ...........Ritalin LA 19.50 METOPROLOL SUCCINATE ( price) Tab long-acting 23.75 mg ..............Betaloc CR Tab long-acting 47.5 mg.................Betaloc CR Tab long-acting 95 mg....................Betaloc CR Tab long-acting 190 mg .................Betaloc CR PIZOTIFEN Tab 500 µg ....................................Sandomigran PROMETHAZINE HYDROCHLORIDE Oral liq 5 mg per 5 ml ....................Promethazine Winthrop Elixir 2.73 3.41 5.88 10.63 21.10 3.10 30 30 30 30 30 100 100 ml 1% 1% Apr-10 Apr-10 (B) Phenergan

RISPERIDONE Oral liq 1 mg per ml ........................Apo-Risperidone 18.35 Tab 0.5 mg.....................................Apo-Risperidone 3.51 Tab 1 mg........................................Apo-Risperidone 6.00 Dr Reddy’s Risperidone Tab 2 mg........................................Apo-Risperidone 11.00 Dr Reddy’s Risperidone Tab 3 mg........................................Apo-Risperidone 15.00 Dr Reddy’s Risperidone Tab 4 mg........................................Apo-Risperidone 20.00 Dr Reddy’s Risperidone

30 ml 60 60 60 60 60

SUMATRIPTAN Tab 50 mg......................................Arrow38.83 100 1% Apr-10 Imigran Sumatriptan Sumagran Tab 100 mg....................................Arrow77.66 100 1% Apr-10 Imigran Sumatriptan Sumagran Note – Arrow-Sumatriptan tab 50 mg 4 tab pack size and 100 mg 2 tab pack size, and Sumagran tab 50 mg and 100 mg, to be delisted 1 April 2010

Effective 1 January 2010

CHOLECALCIFEROL ( price) Tab 50,000 iu .................................Cal-d-Forte CLINDAMYCIN ( price) Inj phosphate 150 mg per ml, 4 ml ...........................................Dalacin C 7.76 12

16.00

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

CODEINE PHOSPHATE ( price) Tab 15 mg......................................PSM Tab 30 mg......................................PSM Tab 60 mg......................................PSM CYCLOSPORIN ( price) Cap 25 mg ....................................Neoral Cap 50 mg ....................................Neoral Cap 100 mg ...................................Neoral Oral liq 100 mg per ml ...................Neoral DEXAMPHETAMINE SULPHATE ( price) Tab 5 mg........................................PSM ERYTHROPOIETIN BETA ( price) Inj 2,000 iu prefilled syringe ............NeoRecormon Inj 3,000 iu prefilled syringe ............NeoRecormon Inj 4,000 iu prefilled syringe ............NeoRecormon Inj 5,000 iu prefilled syringe ............NeoRecormon Inj 6,000 iu prefilled syringe ............NeoRecormon Inj 10,000 iu prefilled syringe ..........NeoRecormon 5.39 8.25 17.76 59.50 118.54 237.08 264.17 16.50 120.18 166.87 193.13 243.26 291.92 395.18 100 100 100 50 50 50 50 ml 100 6 6 6 6 6 6 1% 1% Mar-10 Mar-10 Staphlex Staphlex 1% Apr-08 (B) 1% 1% 1% Mar-08 Mar-08 Mar-08 (B) (B) (B)

FLUCLOXACILLIN SODIUM Cap 250 mg ...................................AFT 32.00 250 Cap 500 mg ...................................AFT 110.00 500 Note – Staphlex cap 250 mg and 500 mg to be delisted 1 March 2010. GADOBUTROL Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml prefilled syringe ......................................Gadovist GADODIAMIDE Inj 287 mg per ml, 10 ml ................Omniscan Inj 287 mg per ml, 15 ml ................Omniscan Inj 287 mg per ml, 10 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 15 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 20 ml pre-filled syringe ......................................Omniscan GLYCEROL ( price) Suppos 3.6 g..................................PSM

253.10 180.00 270.00 220.00 330.00 440.00 6.00

5 10 10 10 10 10 20

HEPARINISED SALINE Inj 100 iu per ml, 5 ml ....................Mayne 103.76 50 Note – Mayne’s brand of heparinised saline inj 100 iu per ml, 5 ml to be delisted 1 March 2010.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

HYDROCORTISONE Crm 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort HYDROCORTISONE BUTYRATE (new listing) Scalp lotn 0.1% ..............................Locoid HYDROCORTISONE BUTYRATE ( price) Lipocream 0.1% ............................Locoid Lipocream Lipocream 0.1% ............................Locoid Lipocream Milky emulsion 0.1% .....................Locoid Crelo Oint 0.1% (brand name change)......Locoid Ointment IODIXANOL (new listing) Inj 320 mg per ml (iodine equivalent), 150 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque IODIXANOL ( price and addition of HSS) Inj 270 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 270 mg per ml (iodine equivalent), 100 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 320 mg per ml (iodine equivalent), 100 ml .........Visipaque IODIXANOL (addition of HSS) Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque IOHEXOL ( price and addition of HSS) Inj 240 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

2.79 2.79 3.65 2.30 6.85 6.85 6.85

15 g 15 g 100 ml 30 g 100 g 100 ml 100 g

670.50 894.00

10 10

5% 5%

Apr-10 Apr-10

(B) (B)

223.50 447.00 223.50 447.00

10 10 10 10

5% 5% 5% 5%

Apr-10 Apr-10 Apr-10 Apr-10

(B) (B) (B) (B)

565.56

Apr-10

(B)

77.80

Apr-10

Iomeron Isovue 50 ml & 100 ml Opitray Ultravist Iomeron Isovue Optiray 20 ml & 30 ml Ultravist Iomeron Isovue Optiray continued...

Inj 300 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

24.00

Apr-10

Inj 300 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

77.80

Apr-10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

continued... Ultraject 50 ml & 75 ml Ultravist 155.60 10 5% Apr-10 Iomeron Isovue Optiray 100 ml, 150 ml & 200 ml Ultraject 125 ml Ultravist (B) Iomeron Isovue Optiray 20 ml & 30 ml Ultraject 30 ml Ultravist 30 ml Iomeron Isovue Optiray Ultraject Ultravist Iomeron Optiray Ultraject Iomeron Isovue Optiray Ultraject 100 ml & 125 ml Ultravist Iomeron Isovue Optiray Ultravist (B)

Inj 300 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

Inj 300 mg per ml (iodine equivalent), 500 ml ....................Omnipaque Inj 350 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

468.00 24.00

6 6

5% 5%

Apr-10 Apr-10

Inj 350 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

77.80

Apr-10

Inj 350 mg per ml (iodine equivalent), 75 ml ......................Omnipaque Inj 350 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

116.70

Apr-10

155.60

Apr-10

Inj 350 mg per ml (iodine equivalent), 200 ml .........................Omnipaque

186.70

Apr-10

Inj 350 mg per ml (iodine equivalent), 500 ml ....................Omnipaque ISONIAZID ( price) Tab 100 mg....................................PSM

780.00 20.00

10 100

Apr-10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

MEDROXYPROGESTERONE ACETATE Inj 150 mg per ml, 1 ml, syringe (new listing)...................Depo-Provera Tab 2.5 mg ( price).......................Provera Tab 5 mg ( price)..........................Provera Tab 10 mg ( price)........................Provera Tab 100 mg ( price)......................Provera Tab 200 mg ( price)......................Provera

7.15 3.09 13.06 6.85 96.50 70.50

1 30 100 30 100 30

1% 1% 1% 1% 1%

Sept-07 Sept-07 Sept-07 Sept-07 Sept-07

Cycrin Cycrin Cycrin (B) (B)

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 21.00 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml vial ......Magnevist MESALAZINE Tab EC 500 mg ..............................Asamax PETHIDINE HYDROCHLORIDE ( price) Tab 50 mg......................................PSM Tab 100 mg....................................PSM PHENOBARBITONE Tab 15 mg......................................PSM Tab 30 mg......................................PSM PINDOLOL Tab 5 mg........................................Apo-Pindolol Tab 10 mg......................................Apo-Pindolol Tab 15 mg......................................Apo-Pindolol QUININE SULPHATE ( price) Tab 200 mg....................................Q 200

184.00 49.50 3.20 4.20 25.00 26.00 5.40 9.19 13.80 17.20

10 100 10 10 500 500 100 100 100 250 1% 1% 1% Mar-10 Mar-10 Mar-10 Pindol Pindol Pindol

RECOMBINANT FACTOR VIII Inj 250 IU .......................................Xyntha 225.00 1 Inj 500 IU .......................................Xyntha 450.00 1 Inj 1,000 IU ....................................Xyntha 900.00 1 Inj 2,000 IU ....................................Xyntha 1,800.00 1 Note – Refacto brand of recombinant factor VIII inj 250 iu, 500 iu, 1,000 iu and 2,000 iu to be delisted 1 April 2010. SILVER SULPHADIAZINE Crm 1% ..........................................Flamazine SOLIFENACIN SUCCINATE Tab 5 mg........................................Vesicare Tab 10 mg......................................Vesicare 12.30 56.50 56.50 50 g 30 30

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

TROPISETRON (addition of HSS) Cap 5 mg .......................................Navoban 77.41 5 1% Mar-10 (B)

Effective 1 December 2009

AMOXYCILLIN Grans for oral liq 125 mg per 5 ml ..Ospamox Grans for oral liq 250 mg per 5 ml .Ospamox ATROPINE SULPHATE ( price and discontinuing HSS) Eye drops 1% ................................Atropt 1.55 1.10 100 ml 100 ml

Feb-10

Amoxil Ranbaxy Amoxicillin (B)

17.36

15 ml

Dec-08

ATROPINE SULPHATE Inj 1200 µg, 1 ml............................AstraZeneca 32.00 50 Note – AstraZeneca inj 1200 µg, 1 ml to be delisted 1 February 2010. BLEOMYCIN SULPHATE Inj 15,000 iu ...................................Blenoxane 680.00 Note – Blenoxane inj 15,000 iu to be delisted 1 February 2010. CALCITRIOL Cap 0.25 µg ..................................Airflow Cap 0.5 µg .....................................Airflow 3.03 5.62 10

30 30

1% 1%

Feb-10 Feb-10

Calcitriol-AFT Rocaltrol Caltriol-AFT Rocaltrol

Note – Calcitriol-AFT cap 0.25 µg and 0.5 µg to be delisted 1 February 2010. CEPHALEXIN MONOHYDRATE Grans for oral liq 125 mg per 5 ml ..Cefalexin Sandoz Grans for oral liq 250 mg per 5 ml ..Cefalexin Sandoz 8.50 11.50 100 ml 100 ml 1% 1% Feb-10 Feb-10 (B) (B)

DOCETAXEL Inj 20 mg........................................Docetaxel 325.00 1 Ebewe Inj 80 mg........................................Docetaxel 1,300.00 1 Ebewe Note – Taxotere inj 20 mg and 80 mg to be delisted 1 February 2010. ETHAMBUTOL HYDROCHLORIDE Tab 100 mg....................................Myambutol FUROSEMIDE Tab 500 mg....................................Urex Forte 57.81 50.00 56 50

1% 1%

Feb-10 Feb-10

Docetaxel Winthrop Taxotere Docetaxel Winthrop Taxotere

HYDROXYETHYL STARCH 200/0.5 PENTASTARCH (amended description) Inj Inf 10% per 500 ml bag ..............StarQuin 10% 216.00 16

Sept-08

Pentaspan

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 December 2009 (continued)

LETROZOLE ( price) Tab 2.5 mg.....................................Femara 146.46 30

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE ( price) Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 210.00 10 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml prefilled Syringe ( price) ........................Magnevist 92.00 5 Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 20 ml ............Magnevist 33.85 1 Note – Magnevist inj 469 mg per ml, 20 ml to be delisted 1 February 2010. PERMETHRIN Lotn 5% .........................................A-Scabies Note – Lyderm crm 5% to be delisted 1 February 2010. 3.65 30 ml 1% Feb-10 Lyderm

POLYETHYLENE GLYCOL WITH SODIUM SULPHATE ( price) Powder, sachets .............................Klean-Prep 16.46 QUETIAPINE ( price) Tab 25 mg......................................Quetapel Tab 100 mg....................................Quetapel Tab 200 mg....................................Quetapel Tab 300 mg ...................................Quetapel 16.78 32.59 56.70 95.40

4 90 90 90 90

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A ABM Hydroxocobalamin ..................................... 23 ACB ................................................................... 28 Acebutolol.......................................................... 28 Alprazolam ......................................................... 26 Amoxycillin .................................................. 30, 39 Amoxycillin clavulanate ................................ 25, 30 Anastrozole ........................................................ 24 Apo-Folic Acid ................................................... 24 Apo-Pindolol ................................................ 20, 38 Apo-Risperidone .......................................... 19, 34 Arimidex ............................................................ 24 Aromasin ..................................................... 22, 24 Arrow-Alprazolam .............................................. 26 Arrow-Metformin.......................................... 24, 30 Arrow-Sumatriptan ........................... 19, 23, 31, 34 Asamax ....................................................... 20, 38 A-Scabies .......................................................... 40 Atropine sulphate ............................................... 39 Atropt ................................................................ 39 Augmentin ................................................... 25, 30 Azatadine maleate .............................................. 28 B Beclazone 50 ..................................................... 28 Beclazone 100 ................................................... 28 Beclazone 250 ................................................... 28 Beclomethasone dipropionate............................. 28 Betaloc CR ................................................... 23, 34 Bisacodyl ........................................................... 31 Blenoxane .......................................................... 39 Bleomycin sulphate ............................................ 39 Blood glucose diagnostic test meter ............. 19, 33 Blood glucose diagnostic test strip ............... 19, 33 C Cabergoline........................................................ 25 Cal-d-Forte................................................... 24, 34 Calamine............................................................ 28 Calcipotriol................................................... 23, 33 Calcitriol ................................................ 23, 30, 39 Calcitriol-AFT ............................................... 23, 30 Cefalexin Sandoz ................................................ 39 Cefepime hydrochloride...................................... 33 Cephalexin monohydrate .................................... 39 Cholecalciferol ............................................. 24, 34 Clindamycin ................................................. 25, 34 Co-trimoxazole ................................................... 28 Codeine phosphate ...................................... 26, 35 Cyclosporin.................................................. 26, 35 Cyclosporin A .................................................... 22 Cyproterone acetate with ethinyloestradiol .... 25, 30 D Daclizumab ........................................................ 33 Daivonex ...................................................... 23, 33 Dalacin C ..................................................... 25, 34 Dasatinib...................................................... 19, 33 Depo-Provera ......................................... 25, 28, 38 Dexamphetamine sulphate............................ 26, 35 Dextrochlorpheniramine maleate ................... 29, 32 Diazepam........................................................... 28 Didronel ....................................................... 25, 30 Dithranol ............................................................ 31 Docetaxel ..................................................... 24, 39 Docetaxel Ebewe ................................................ 39 Dostinex ............................................................ 25 Dr Reddy’s Risperidone................................ 19, 34 E Elocon ......................................................... 24, 30 Ensure Plus........................................................ 22 Erythropoietin beta ............................................. 35 Estelle 35-ED ............................................... 25, 30 Ethambutol hydrochloride ................................... 39 Etidrate ........................................................ 25, 30 Etidronate disodium ..................................... 25, 30 Exemestane ................................................. 22, 24 F Femara .............................................................. 40 Ferrous gluconate with ascorbic acid .................. 31 Flamazine..................................................... 20, 38 Flecainide acetate......................................... 23, 33 Fleet................................................................... 31 Flixonase Hayfever & Allergy .............................. 20 Fluarix ................................................................ 21 Flucloxacillin sodium .................................... 20, 35 Fludara............................................................... 31 Fludarabine phosphate ....................................... 31 Fluticasone propionate ....................................... 20 Fluvax ................................................................ 21 Folic acid ........................................................... 24 Furosemide ........................................................ 39 G Gadobutrol ......................................................... 35 Gadodiamide...................................................... 35 Gadovist ............................................................ 35 Gastrografin ................................................. 38, 40 Genotropin ................................................... 22, 25 Gliben ................................................................ 28 Glibenclamide .................................................... 28 Glycerol ....................................................... 24, 35 Goserelin acetate ......................................... 23, 33 Growth hormone biosynthetic human ................. 22 H Healtheries Iron with Vitamin C ........................... 31 Heparinised saline .............................................. 35 Hydrocortisone .................................................. 36

Index

Pharmaceuticals and brands Hydrocortisone butyrate ......................... 24, 31, 36 Hydrocortisone with natamycin and neomycin .... 24 Hydroderm Lotion .............................................. 24 Hydroxocobalamin ....................................... 23, 33 Hydroxyethyl starch 200/0.5 .............................. 39 I Interferon alpha-2a ............................................. 31 Interferon alpha-2a with ribavirin......................... 32 Imigran ........................................................ 23, 31 Influenza vaccine................................................ 21 Invirase .............................................................. 28 Iodixanol ............................................................ 36 Iohexol ............................................................... 36 Iron sucrose....................................................... 33 Isoniazid ...................................................... 25, 37 Isotane 10.......................................................... 28 Isotane 20.......................................................... 28 Isotretinoin ......................................................... 28 K Klean-Prep ......................................................... 40 L Letara .......................................................... 19, 33 Letrozole ................................................ 19, 33, 40 Locoid ......................................................... 24, 36 Locoid Crelo .......................................... 24, 31, 36 Locoid Lipocream ........................................ 24, 36 Locoid Ointment................................................. 36 Lyderm ........................................................ 23, 30 M Magnevist .................................................... 38, 40 Maxipime ........................................................... 33 MDS Quick Card ................................................ 21 Medroxyprogesterone acetate................. 25, 28, 38 Meglumine diatrizoate with sodium amidotrizoate ............................................ 38, 40 Meglumine gadopentetate............................. 38, 40 Mesalazine ................................................... 20, 38 Metformin hydrochloride .............................. 24, 30 Methylphenidate hydrochloride extended-release ....................................... 19, 34 Metoprolol succinate .................................... 23, 34 Micanol.............................................................. 31 Mometasone furoate .................................... 24, 30 Myambutol......................................................... 39 N Navoban ............................................................ 39 Neoral .................................................... 22, 26, 35 NeoRecormon .................................................... 35 Norditropin SimpleXx 5 mg ........................... 22, 31 Norditropin SimpleXx 10 mg ......................... 22, 31 Norditropin SimpleXx 15 mg ......................... 22, 31 O Omnipaque .................................................. 36, 37 Omniscan .......................................................... 35 On Call Advanced ......................................... 19, 33 Oral feed 1.5kcal/ml ........................................... 22 Ospamox ........................................................... 39 Oxaliplatin .......................................................... 26 P Paracetamol with codeine .................................. 20 ParaCode ........................................................... 20 Pentastarch........................................................ 39 Permethrin ............................................. 23, 30, 40 Pethidine hydrochloride ................................ 26, 38 Phenobarbitone ............................................ 26, 38 Pilocarpine ................................................... 28, 29 Pilopt ........................................................... 28, 29 Pimafucort ................................................... 24, 36 Pindolol ....................................................... 20, 38 Pizotifen ....................................................... 24, 34 Polaramine Colour-Free Repetab ........................ 32 Polaramine Repetab ........................................... 29 Polyethylene glycol with sodium sulphate ........... 40 Pregnancy tests - HCG urine ........................ 21, 27 Promethazine Winthrop Elixir ........................ 19, 34 Pro-Pam ............................................................ 28 Promethazine hydrochloride ......................... 19, 34 Provera ........................................................ 25, 38 Q Q 200 .......................................................... 26, 38 Quetapel ............................................................ 40 Quetiapine.......................................................... 40 Quinine sulphate .......................................... 26, 38 R Ranbaxy Amoxicillin ........................................... 30 Recombinant factor viii....................................... 38 Recombinant human growth hormone ................ 22 Risperidone.................................................. 19, 34 Ritalin LA ..................................................... 19, 34 Roferon-A .......................................................... 31 Roferon RBV Combination Pack ......................... 32 Roferon RBV Combination Pack Starter Kit ......... 32 S Sandomigran ............................................... 24, 34 Saquinavir .......................................................... 28 Sildenafil ............................................................ 23 Silvazine ............................................................ 31 Silver sulphadiazine ................................ 20, 31, 38 Solifenacin succinate ................................... 20, 38 Somatropin ............................................ 22, 25, 31 Sprycel ........................................................ 19, 33 StarQuin 10% ..................................................... 39

Index

Pharmaceuticals and brands Sumagran .................................................... 23, 31 Sumatriptan ..................................... 19, 23, 31, 34 T Tambocor .................................................... 23, 33 Tambocor CR .............................................. 23, 33 Triamizide .......................................................... 28 Triamterene with hydrochlorothiazide.................. 28 Trimipramine maleate ......................................... 32 Tripress ............................................................. 32 Trisul ................................................................. 28 Tropisetron ........................................................ 39 U Urex Forte .......................................................... 39 V Vaxigrip ............................................................. 21 Venofer .............................................................. 33 Vesicare....................................................... 20, 38 Viagra ................................................................ 23 Visipaque ........................................................... 36 W Winthrop Elixir .................................................... 34 Wool fat with mineral oil ..................................... 24 X Xyntha ............................................................... 38 Z Zadine................................................................ 28 Zenapax ............................................................. 33 Zoladex ........................................................ 23, 33

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 February 2010

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February 2010 Cumulative for January and February 2010 Section H cumulative for December 2009, and January, February 2010 Contents Summary of PHARMAC decisions effective 1 February 2010 …. 3 Aromatase…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.